Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome

Psychological Medicine

Volumn 28, Issue 2, 1998, Pages 285-293

  Scott, L V ^a   Burnett, F ^a   Medbak, S ^a   Dinan, T G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NALOXONE; OPIATE ANTAGONIST;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE;

ADRENOCORTICOTROPIC HORMONE; ADULT; AREA UNDER CURVE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; NEURAL PATHWAYS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, OPIOID;

EID: 0031969736     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291797006260     Document Type: Article

References (61)

1. Al-Damluji, S., Bouloux, P., White, A. & Besser, G. M. (1990). The role of α-2 adrenoceptors in the control of ACTH secretion: interaction with the opioid system. Neuroendocrinology 51, 76-81.
2. American Psychiatric Association (1987). Diagnostic and Statistical Manual, 3rd edn (revised). American Psychiatric Association: Washington.
3. Antoni, F. (1993). Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Frontiers in Neuroendocrinology 14, 76-122.
4. Bakheit, A., Behan, P., Dinan, T. G., Gray, C. E. & O'Keane, V. (1992). Possible upregulation of the 5HT1a receptor in patients with post-viral fatigue syndrome. British Medical Journal 304, 1010-1012.
5. Beam, J., Allain, T., Coskeran, P., Munro, N., Butler, J., McGregor, A. & Wessely, S. (1995). Neuroendocrine responses to D-fenfluramine and insulin-induced hypoglycaemia in chronic fatigue syndrome. Biological Psychiatry 37, 245-252.
6. Blevins, S. S., Dobs, A. S. & Wand, G. S. (1994). Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency. American Journal of Medical Sciences 308, 167-170.
7. Cleare, A. J., Bearn, J., Allain, T., McGregor, A., Wessely, R. & O'Keane, V. (1995). Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. Journal of Affective Disorders 34, 283-889.
8. DeBold, C., Sheldon, W. & DeCherney, G. (1983). Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. Journal of Clinical Investigation 73, 533-538.
9. Delitala, G., Grossman, A. & Besser, M. (1983). Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. Neuroendocrinology 37, 275-279.
10. Delitala, G., Trainer, P. J., Oliva, O., Fanciulli, G. & Grossman, A. B. (1994). Opioid peptide and α-adreno-receptor pathways in the regulation of pituitary-adrenal axis in man. Journal of Endocrinology 141, 163-168.
11. Demitrack, M. A., Gold, P. W., Dale, J. K., Krahn, D. D., Kling, M. A. & Straus, S. E. (1989). Plasma and cerebrospinal fluid metabolism in patients with chronic fatigue syndrome. Biological Psychiatry, 32, 1065-1077.
12. Demitrack, M. A., Dale, J. K., Laue, L., Listwak, S. J., Kruesi, M. J. P., Chrousos, G. P. & Gold, P. W. (1991). Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Journal of Clinical Endocrinology and Metabolism 73, 1224-1234.
13. Dash, R. J., England, B. J., Midgley, A. R. & Niswender, G. D. (1975). A specific non-chromatographic radioimmunoassay for human cortisol. Steroids 26, 647.
14. Dinan, T. G. (1996). Serotonin and the regulation of the hypothalamic-pituitary-adrenal axis function. Life Sciences 58, 1683-1694.
15. Dinan, T. G., Majeed, T., Lavelle, E., Scott, L., Berti, C. & Behan, P. (1997). Serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 22, 261-268.
16. Estienne, M. J., Kesner, J. S., Barb, C. R., Kraeling, M. J. & Rampecek, G. B. (1988). On the site of action of naloxone-stimulated cortisol secretion in gilts. Life Sciences 43, 161-166.
17. Extien, I., Pottash, A. L. C. & Gold, M. S. (1982). A possible receptor of dysfunction in some depressive disorders. Annals of New York Academy of Sciences 398, 113-119.
18. Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M., Dobbins, J. G., Komaroff, A. & the International Chronic Fatigue Syndrome Study Group (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 12, 953-959.
19. Gaitan, D., Loosen, P. T. & Burns, D. (1993). Plasma ACTH response to naloxone in major depressive disorder (MDD), chronic alcoholism (ALC), Cushings disease (CD) and normal subjects (NL). Program of the Endocrine Society USA (abstr) No. 752C, 238.
20. Garrick, N. A., Hill, J. L., Szele, F. G., Tomai, T. P. & Gold, P. W. (1987). Corticotropin-releasing factor: a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm. Endocrinology 121, 1329-1334.
21. Gold, P. W., Licinio, J., Wong, M. & Chrousos, G. P. (1991). Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Annals of New York Academy of Sciences 77, 716-729.
22. Grossman, A. & Besser, G. M. (1982). Opiates control ACTH release through a noradrenergic mechanism. Clinical Endocrinology 17, 287-290.
23. Grossman, A., Gaillard, R. C., McCartney, P., Rees, L. H. & Besser, G. M. (1982). Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rhythm. Clinical Endocrinology 17, 279-286.
24. Grossman, A. & Costa, A. (1993). The regulation of hypothalamic CRH : impact of in vitro studies on the central control of the stress response. Functional Neurology 8, 325-334.
25. Grossman, A., Moult, P. J. A., Cunnah, D. & Besser, G. M. (1986). Different opioid mechanisms are involved in the modulation of gonadotrophin and ACTH release in man. Neuroendocrinology 42, 357-360.
26. Heninger, G. R., Charney, D. S. & Sternberg, D. E. (1984). Serotonergic function in depression. Prolactin responses to intravenous tryptophan in depressed patients and healthy subjects. Archives of General Psychiatry 41, 398-402.
27. Hockings, G. I., Grice, J. E., Ward, W. K., Walters, M. M., Jensen, G. R. & Jackson, R. V. (1993). Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in post-traumatic stress disorder. Biological Psychiatry 33, 585-593.
28. Hockings, G. I., Grice, J. E., Walters, M. M., Crosbie, G. V., Torpy, D. J. & Jackson, R. V. (1995). A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans : evidence that naloxone stimulates endogenous corticotropin-releasing hormone. Neuroendocrinology 61, 198-206.
29. Holsboer, F., Gerken, A., Von Bardeleben, U., Grimm, W., Beyer, H., Muller, O. A. & Stalla, G. K. (1986). Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor (h-CRF) in depression. New England Journal of Medicine 311, 1127.
30. Inder, W. J., Ellis, M. J., Evans, M. J. & Donald, R. A. (1995a). A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology 43, 425-431.
31. Inder, W. J., Joyce, P. R., Ellis, M. J., Evans, M. J., Livesey, J. H. & Donald, R. A. (1995b). The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides. Clinical Endocrinology 43, 283-290.
32. Inder, W. J., Hellemans, J., Ellis, M. J., Evans, M. J., Livesey, J. H. & Donald, R. A. (1995c). Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes. Journal of Clinical Endocrinology and Metabolism 80, 244-247.
33. Jackson, R. V., Grice, J. E., Hockings, G. I. & Torpy, D. J. (1995). Naloxone-induced ACTH release : mechanism of action in humans. Clinical Endocrinology 43, 423-424.
34. Joyce, P. R. & Donald, R. A. (1987). Naloxone augments the hypothalamic-pituitary-adrenal axis response to methylphenidate in normal subjects. Journal of Psychiatric Research 21, 197-200.
35. Judd, L. L., Janowsky, D. S., Zettner, A., Huey, L. Y. & Takahashi, K. I. (1981). Effects of naloxone hydrochloric on cortisol levels in patients with affective disorder and normal controls. Psychiatry Research 4, 277-283.
36. Lamberts, S., Verleun, S., Oosteron, R., DeJong, F. & Hackeng, W. (1984). Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. Journal of Clinical Endocrinology and Metabolism 58, 298-303.
37. Lesch, K. P., Rupprecht, R., Poten, B., Muller, U., Sohnle, K., Fritze, J. & Schulte, H. M. (1989). Endocrine responses to 5-HT1a receptor activation by ipsapirone in humans. Biological Psychiatry 26, 203-205.
38. Liposits, Z. C., Phelix, C. & Paull, W. K. (1987). Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus. Histochemistry 86, 541-549.
39. Michelson, D., Licinio, J. & Gold, P. W. (1995). Mediation of the stress response by the hypothalamic-pituitary-adrenal axis. In Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD (ed. M. J. Friedman, D. S. Charney and A. Y. Deutch), pp. 225-238. Lippincott-Raven Publishers: Philadelphia.
40. Nikolaris, K., Pfeiffer, A., Stalla, K. G. & Herz, A. (1987). The role of CRF in the release of ACTH by opiate agonists and antagonists in rats. Brain Research 421, 373-376.
41. O'Keane, V. & Dinan, T. G. (1991). Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry 148, 1009-1015.
42. Raff, H. & Findling, J. W. (1989). A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clinical Chemistry 35, 595-600.
43. Satta, M. A., Maussier, M. L., DeRosa, G., Valenza, V., Testa, A., Salenich, I., Napolitano, G. & Monaco, F. (1992). Effects of naloxone on adrenocorticotrophin (ACTH) and cortisol in obese subjects. Hormonal Metabolic Research 24, 44-45.
44. Scott, L. V. & Dinan, T. G. (1997). Urinary free cortisol levels in chronic fatigue syndrome, in depression and in health. Journal of Affective Disorders (in the press).
45. Sharpe, M., Clements, A. & Cowen, P. (1996). Increased prolactin response to buspirone in chronic fatigue syndrome. Journal of Affective Disorders 41, 71-76.
46. Shorter, E. (1993). Chronic fatigue syndrome in historical perspective. In Ciba Foundation Symposium 173 Chronic Fatigue Syndrome. (ed. D. Chadwick, J. Marsh and K. Ackrill), pp. 6-16. Wiley: Chichester. 6-16.
47. Statistical Graphics Corporation (1987). SGCS: New York.
48. Stubbs, W. A., Delitala, G. & Jones, A. (1978). Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet ii, 1225-1227.
49. Swanson, L. W., Sawchencko, P. E., Rivier, J. & Vale, W. W. (1983). Organization of ovine corticotropin-releasing factor like immunoreactive cells and fibers in rat brain: an immunohistochemical study. Neuroendocrinology 36, 165-186.
50. Taylor, T., Dluhy, R. G. & Williams, G. H. (1983). Beta-endorphin suppresses adrenocorticotrophin and cortisol levels in normal human subjects. Journal of Clinical Endocrinology and Metabolism. 57, 592-596.
51. Terenius, L. & Wahlstrom, A. (1978). Physiological and clinical relevance of endorphins. In Centrally Acting Peptides (ed. J. Hughes), pp. 161-178. Baltimore University Park Press: Maryland.
52. Torpy, D. J., Jackson, R. V., Grice, G. E., Hockings, G. I., Strakosch, C. R. & Topliss, D. J. (1993). Naloxone stimulation of ACTH secretion during petrosal sinus sampling in Cushing's syndrome. Clinical and Experimental Pharmacology and Physiology 20, 299-302.
53. Torpy, D. J., Grice, J. E., Hockings, G. I., Crosbie, G. V., Walters, M. M. & Jackson, R. V. (1995). The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of the two drugs acting on noradrenergic control of adrenocorticotropin secretion. Journal of Clinical Endocrinology and Metabolism 80, 802-806.
54. Tsagarakis, S., Holly, J. M. P., Rees, L. H., Besser, G. M. & Grossman, A. (1989). Morphine directly modulates the release of stimulated corticotropin-releasing factor-41 from the rate hypothalamus in vitro. Endocrinology 124, 2330-2335.
55. Volavka, J., Cho, D., Mallya, A. & Bauman, A. (1979). Naloxone increases ACTH and cortisol levels in normal man. New England Journal of Medicine 300, 1056-1057.
56. Wesseley, S. & Powell, R. (1989). Fatigue syndromes: a comparison of chronic 'postviral' fatigue with neuromuscular and affective disorders. Journal of Neurology, Neurosurgery and Psychiatry 42, 940-948.
57. Wittert, G. A., Stewart, D. E., Graves, M. P., Ellis, M. J., Evans, M. J., Wells, J. E., Donald, R. A. & Espiner, R. A. (1991). Plasma corticotropin releasing factor and vasopressin responses to exercise in normal man. Clinical Endocrinology (Oxf) 35, 311-317.
58. Yatham, L. N., Morehouse, R. L., Chisholm, B. T., Haase, D. A., MacDonald, D. D. & Marrie, T. J. (1995). Neuroendocrine assessment of serotonin function in chronic fatigue syndrome. Canadian Journal of Psychiatry 40, 92-96.
59. Yehuda, R., Southwick, S. M., Nussbaum, G., Wahby, V., Giller, E. L. & Mason, J. (1990). Low urinary cortisol excretion in patients with posttraumatic stress disorder. Journal of Nervous and Mental Disorders 187, 366-369.
60. Zis, A. P., Grant, B. E. K., Remick, R. A. & Clark, C. M. (1989). Cortisol response to naloxone in depression. International Congress Series Excerpta Medica 899, 66.
61. Zis, A. P. & Garland, J. E. (1991). Opioid peptides and depression. In Clinical Endocrinology and Metabolism (ed. E. Ur), vol. 5, pp. 97-117. Balliérè Tindall: London.